Cargando…

Defining Insulin Resistance From Hyperinsulinemic-Euglycemic Clamps

OBJECTIVE: This study was designed to determine a cutoff point for identifying insulin resistance from hyperinsulinemic-euglycemic clamp studies performed at 120 mU/m(2) ⋅ min in a white population and to generate equations from routinely measured clinic and blood variables for predicting clamp-deri...

Descripción completa

Detalles Bibliográficos
Autores principales: Tam, Charmaine S., Xie, Wenting, Johnson, William D., Cefalu, William T., Redman, Leanne M., Ravussin, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3379600/
https://www.ncbi.nlm.nih.gov/pubmed/22511259
http://dx.doi.org/10.2337/dc11-2339
Descripción
Sumario:OBJECTIVE: This study was designed to determine a cutoff point for identifying insulin resistance from hyperinsulinemic-euglycemic clamp studies performed at 120 mU/m(2) ⋅ min in a white population and to generate equations from routinely measured clinic and blood variables for predicting clamp-derived glucose disposal rate (GDR), i.e., insulin sensitivity. RESEARCH DESIGN AND METHODS: We assembled data from hyperinsulinemic-euglycemic clamps (120 mU/m(2) ⋅ min insulin dose) performed at the Pennington Biomedical Research Center between 2001 and 2011. Subjects were divided into subjects with diabetes (n = 51) and subjects without diabetes (n = 116) by self-report and/or fasting glucose ≥126 mg/dL. RESULTS: We found that 75% of individuals with a GDR <5.6 mg/kg fat-free mass (FFM) + 17.7 ⋅ min were truly insulin resistant. Cutoff values for GDRs normalized for body weight, body surface area, or FFM were 4.9 mg/kg ⋅ min, 212.2 mg/m(2) ⋅ min, and 7.3 mg/kgFFM ⋅ min, respectively. Next, we used classification tree models to predict GDR from routinely measured clinical and biochemical variables. We found that individual insulin resistance could be estimated with good sensitivity (89%) and specificity (67%) from the homeostasis model assessment of insulin resistance (HOMA-IR) >5.9 or 2.8< HOMA-IR <5.9 with HDL <51 mg/dL. CONCLUSIONS: We developed a cutoff for defining insulin resistance from hyperinsulinemic-euglycemic clamps. Moreover, we now provide classification trees for predicting insulin resistance from routinely measured clinical and biochemical markers. These findings extend the clamp from a research tool to providing a clinically meaningful message for participants in research studies, potentially providing greater opportunity for earlier recognition of insulin resistance.